Trillium Therapeutics Inc. appointed Yaping Shou as chief medical officer.
Shou joins Trillium from Takeda Pharmaceutical Co. Ltd., where she most recently served as executive medical director.
Ontario-based Trillium Therapeutics is a clinical-stage immuno-oncology company developing therapies for the treatment of cancer.
